|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Andrew TeasdalePublisher: John Wiley & Sons Inc Imprint: John Wiley & Sons Inc Edition: 2nd Edition Dimensions: Width: 17.80cm , Height: 3.00cm , Length: 25.40cm Weight: 1.168kg ISBN: 9781119551218ISBN 10: 1119551218 Pages: 544 Publication Date: 08 April 2022 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Out of stock ![]() The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsReviewsAuthor InformationAndrew Teasdale, PhD, is a senior principal scientist with AstraZeneca and a member of ICH Q3C, Q3D, Q3E Expert working groups as well as an industry advisor to ICH M7. He received his doctorate in organic chemistry from Durham University. He is the inventor of the purge factor concept applied to risk assessment of mutagenic impurities and has authored over 30 papers on that subject. Tab Content 6Author Website:Countries AvailableAll regions |